Eli Lilly expects to miss mark in fourth quarter

Article Abstract:

Eli Lilly and Co. is forecasting lower-than-expected results for the 2001 fourth-quarter. The company, which has been hurt by the sales decline in its antidepressant drug, also forecasted low results for the fiscal 2001 and 2002 periods.

Forecasts and trends, Eli Lilly and Co., LLY

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

Bristol-Myers earnings rise on strong U.S. sales

Article Abstract:

Bristol-Myers Squibb Co. posted strong earnings for the 1999 fourth-quarter. The company's earnings per diluted share increased more than one-and-a-half times from 20 cents in 1998 to 52 cents in 1999.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

Bristol-Myers says net increased 11%, meeting estimates

Article Abstract:

Bristol-Myers Squibb Co. posted an increase of 11% in their net income for the 2000 fourth-quarter. The company posted $1.16 billion (1.23 billion euros) in net income for the period.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


subjects list: United States, Pharmaceutical industry, Drugs, Finance, Bristol-Myers Squibb Co., BMY